Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
Just nowCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
32m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
32m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
32m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
33m agoFirst Quantum Minerals Reports First Quarter 2026 Results
Renovorx Inc logo

Renovorx Inc

About

Renovorx Inc (NASDAQ:RNXT) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 23 2026
RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting
Apr 14 2026
Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting
Apr 8 2026
RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum
Apr 1 2026
RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
Mar 30 2026
RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update

Financials

Revenue
$1.12 M
Market Cap
$46.34 M
EPS
-0.32

Community Chat

Ask AI

6ix6ixAIEvents